Cargando…
Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes
BACKGROUND: Platelet hyperaggregability is a pro-thrombotic feature of type-2 diabetes, associated with low levels of the antioxidant glutathione (GSH). Clinical delivery of N-acetylcysteine (NAC), a biosynthetic precursor of GSH, may help redress a GSH shortfall in platelets, thereby reducing throm...
Autores principales: | Gibson, Kyle R, Winterburn, Tim J, Barrett, Fiona, Sharma, Sushma, MacRury, Sandra M, Megson, Ian L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120650/ https://www.ncbi.nlm.nih.gov/pubmed/21600014 http://dx.doi.org/10.1186/1475-2840-10-43 |
Ejemplares similares
-
N-Acetylcysteine inhibits platelet–monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial
por: Treweeke, A. T., et al.
Publicado: (2012) -
Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis
por: Treweeke, A., et al.
Publicado: (2017) -
A Case of Strangulated Inguinal Hernia
por: MacRury, C.
Publicado: (1874) -
Penetrating Wound of the Head, Protrusion and Loss of Cerebral Substance: Recovery
por: MacRury, C.
Publicado: (1874) -
Rhinoplastic Operation
por: MacRury, C. M.
Publicado: (1874)